Rapid improvement of Clinical Disease Activity Index (CDAI) at 3 months predicts a preferable CDAI outcome at 1 year in active rheumatoid arthritis patients treated with tocilizumab: results from an observational investigation of daily clinical practice.
Rapid improvement of Clinical Disease Activity Index (CDAI) at 3 months predicts a preferable CDAI outcome at 1 year in active rheumatoid arthritis patients treated with tocilizumab: results from an observational investigation of daily clinical practice.
复制标题
3 个月时临床疾病活动指数 (CDAI) 的快速改善预示着接受托珠单抗治疗的活动性类风湿关节炎患者 1 年时 CDAI 的更好结果：日常临床实践观察性调查的结果。
DOI：
--
复制
发表时间：
2016
期刊：
影响因子：
--
通讯作者：
Kawakami A.
中科院分区：
文献类型：
--
作者：
Kawashiri SY;Nishino A;Suzuki T;Nakashima Y;Horai Y;Ueki Y;Aramaki T;Fujikawa K;Nakashima M;Okada A;Migita K;Mizokami A;Matsuoka N;Mine M;Sakito S;Iwamoto N;Ichinose K;Tamai M;Nakamura H;Origuchi T;Aoyagi K;Eguchi K;Kawakami A.
